View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Dashboards
  2. Surveys
June 10, 2021

Digital transformation: Investment in cybersecurity remain stable

Investment in cybersecurity amid the growing pace of digital transformation has remained relatively stable in the pharmaceutical industry.

GlobalData conducted a survey to identify the percentage of businesses investing in cybersecurity in 2019 and 2020.

An assessment of the survey results shows that 72% of the respondents in 2020 said that they were investing in cybersecurity. The percentage was 73% in 2019.

In 2020, around 22% of the pharmaceutical industry IT professionals stated that their businesses were not investing in cybersecurity. This increased by two percentage points on a year-on-year basis.

The percentage of respondents answering ‘Don’t Know’ dropped from 7% in 2019 to 6% in 2020.

The data also indicates the misalignment between pharma executives and IT leaders on current investment priorities has marginally decreased.

Digital transformation- Investment in cybersecurity remain stable

Investment in Cybersecurity- 2019 vs. 2020 Date

The analysis is based on GlobalData, Emerging Technologies Survey 2020 and GlobalData, Emerging Technologies Survey 2019. The 2020 survey was fielded between 29 May and 9 July 2020.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology